Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05599984 |
|---|---|
| Brief Title: | Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors |
| First Submitted : | October 28, 2022 |
| First Submitted that Met QC Criteria : | October 28, 2022 |
| First Posted : | October 31, 2022 |
| Last Update Submitted that Met QC Criteria : | May 13, 2024 |
| Last Update Posted : | May 14, 2024 (Estimate) |